Surfactant protein D in respiratory and non-respiratory diseases

GL Sorensen - Frontiers in medicine, 2018 - frontiersin.org
Surfactant protein D (SP-D) is a multimeric collectin that is involved in innate immune
defense and expressed in pulmonary, as well as non-pulmonary, epithelia. SP-D exerts …

Chronic obstructive pulmonary disease biomarkers and their interpretation

RA Stockley, DMG Halpin, BR Celli… - American journal of …, 2019 - atsjournals.org
The pathology and impact of chronic obstructive pulmonary disease (COPD) results from an
abnormal inflammatory process resulting in tissue damage with ineffective repair in …

At the root: defining and halting progression of early chronic obstructive pulmonary disease

FJ Martinez, MLK Han, JP Allinson, RG Barr… - American journal of …, 2018 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a prevalent, heterogeneous disorder with
varying presentation and progression but with a limited number of disease-modifying …

[HTML][HTML] Animal models reflecting chronic obstructive pulmonary disease and related respiratory disorders: translating pre-clinical data into clinical relevance

L Tanner, AB Single - Journal of innate immunity, 2020 - karger.com
Chronic obstructive pulmonary disease (COPD) affects the lives of an ever-growing number
of people worldwide. The lack of understanding surrounding the pathophysiology of the …

Diagnosis and treatment of early chronic obstructive lung disease (COPD)

JY Choi, CK Rhee - Journal of clinical medicine, 2020 - mdpi.com
Chronic obstructive lung disease (COPD) is responsible for substantial rates of mortality and
economic burden, and is one of the most important public-health concerns. As the disease …

The AGE-RAGE axis and RAGE genetics in chronic obstructive pulmonary disease

A Sharma, S Kaur, M Sarkar, BC Sarin… - Clinical Reviews in …, 2021 - Springer
Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of lung diseases
limiting the airflow due to narrowing of airways, chronic bronchitis and emphysema that …

Protein biomarkers for COPD outcomes

KA Serban, KA Pratte, RP Bowler - Chest, 2021 - Elsevier
COPD is a clinically heterogeneous syndrome characterized by injury to airways, airspaces,
and lung vasculature and usually caused by tobacco smoke and/or air pollution exposure …

Omics and the search for blood biomarkers in chronic obstructive pulmonary disease. Insights from COPDGene

EA Regan, CP Hersh, PJ Castaldi… - American journal of …, 2019 - atsjournals.org
There is an unmet need for blood biomarkers in diagnosis and prognosis of chronic
obstructive pulmonary disease (COPD). The search for these biomarkers has been …

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD

KA Pratte, JL Curtis, K Kechris, D Couper, MH Cho… - Respiratory …, 2021 - Springer
Background Soluble receptor for advanced glycation end products (sRAGE) is a proposed
emphysema and airflow obstruction biomarker; however, previous publications have shown …

Advances in design strategies of multiplex electrochemical aptasensors

I Grabowska, M Hepel, K Kurzątkowska-Adaszyńska - Sensors, 2021 - mdpi.com
In recent years, the need for simple, fast, and economical detection of food and
environmental contaminants, and the necessity to monitor biomarkers of different diseases …